Category: Joint ventures/collaborations
-
Lilly Licensing Autoimmune Therapy in $400M Deal
Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system.
-
Arizona Medical Marijuana Operators Merge to Create Super Dispensary
Two of the biggest medical marijuana operators in Arizona – Modern Flower and Harvest – have merged to create a super dispensary.
-
Grant Funding Automated Genome Editing System
A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique.
-
Start-Up Applying Artificial Intelligence to New Drug Uses
A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs.
-
Glaxo Using Artificial Intelligence for Drug Discovery
Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets.
-
Start-Up to Offer Neuro Disorder Speech Analytics App
A start-up enterprise in Germany is commercializing a software app to detect early signs of cognitive decline, found in dementia and other neurodegenerative disorders.
-
Organ Chips to be Studied on Space Station
A range of biological functions will be assessed with model organs on plastic chips in a series of experiments on the International Space Station.
-
Engineered Algae Doubles Bio-Oil Content
An industry biotechnology team created a genetically-engineered variety of algae that doubles its oil content without limiting its ability to grow.
-
Exosuit Prototype Unveiled for Stroke Survivors
An assistive device with sensors and motors designed to help people with stroke and other muscle disorders walk more normally was demonstrated on 16 June.
-
Coalition to Make 10,000 Open-Access Synthetic Genes
A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers.